|
STK38L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.82139999988551E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.07020000001046E-06 |
| Normal-vs-Stage2 |
4.324900E-03 |
| Normal-vs-Stage3 |
2.031400E-04 |
| Normal-vs-Stage4 |
7.28479999989595E-07 |
| Stage1-vs-Stage2 |
9.985000E-01 |
| Stage1-vs-Stage3 |
9.562200E-01 |
| Stage1-vs-Stage4 |
8.799700E-02 |
| Stage2-vs-Stage3 |
9.728400E-01 |
| Stage2-vs-Stage4 |
3.101400E-01 |
| Stage3-vs-Stage4 |
1.783760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42439999997845E-06 |
| Normal-vs-AfricanAmerican |
1.53780000000658E-06 |
| Normal-vs-Asian |
4.001800E-01 |
| Caucasian-vs-AfricanAmerican |
3.915500E-02 |
| Caucasian-vs-Asian |
4.658400E-01 |
| AfricanAmerican-vs-Asian |
1.725780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.43120000000108E-05 |
| Normal-vs-Female |
1.13020000025443E-08 |
| Male-vs-Female |
3.918300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.145700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.021400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.72259999989366E-07 |
| Normal-vs-Age(81-100Yrs) |
9.77300000000181E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.852000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.186000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.579900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.346400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.680300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.402600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.763800E-02 |
| Normal-vs-Grade 2 |
1.082900E-03 |
| Normal-vs-Grade 3 |
2.52199999994929E-07 |
| Normal-vs-Grade 4 |
2.18619999999836E-05 |
| Grade 1-vs-Grade 2 |
9.151000E-01 |
| Grade 1-vs-Grade 3 |
4.375600E-01 |
| Grade 1-vs-Grade 4 |
4.763200E-01 |
| Grade 2-vs-Grade 3 |
2.623900E-02 |
| Grade 2-vs-Grade 4 |
9.633500E-02 |
| Grade 3-vs-Grade 4 |
7.935400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.37650000000089E-05 |
| Normal-vs-ccB subtype |
4.300500E-03 |
| ccA subtype-vs-ccB subtype |
2.397200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91602999999319E-05 |
| Normal-vs-N1 |
4.399800E-03 |
| N0-vs-N1 |
5.029200E-01 |
|
|
